Two Luminaries to Present Keynote Speeches at the 9th Singapore International Energy Week

SINGAPORE /PRNewswire/ — Rachel Kyte, CEO of Sustainable Energy for All (SE4All) and Special Representative of the United Nations (UN) Secretary General, and David Gray, Chairman of the Office of Gas and Electricity Markets (Ofgem) of the UK, will be sharing their perspectives on the opportunities and challenges in the face of today’s ‘New Energy Realities’ at the Opening Keynote Address of the 9th Singapore International Energy Week (SIEW).

Ms Kyte will share insights from the UN on sustainable energy, and how global energy cooperation can address the need for greener and smarter energy solutions. Mr Gray will speak on the evolving role of the regulator in energy markets, especially in the transition to a low-carbon economy.

For the first time, the critical issue of energy access in Asia Pacific will be addressed at SIEW, through the inaugural Energy Access Forum. Jointly organised by the UN Economic and Social Commission for Asia and the Pacific, and the Energy Market Authority of Singapore, the Forum brings together international organisations, governments, industry and other stakeholders to develop new and innovative policy options and business models for enhanced energy access.

The strong line-up of energy thought leaders at the Singapore Energy Summit continues to expand. Latest confirmed speakers include:

Robin Dunnigan, Deputy Assistant Secretary for Energy Diplomacy, Bureau of Energy Resources, US Department of State
Gireesh B. Pradhan, Chairperson, Central Electricity Regulatory Commission, India
Agneta Rising, Director General, World Nuclear Association
Tang Kin Fei, CEO, Sembcorp Industries
Jon Moore, CEO, Bloomberg New Energy Finance
Dr Matthew Peloso, Founder and CEO, Sun Electric
Yoshihiko Kimata, Representative in South East Asia, Osaka Gas
Tony Wood, Energy Program Director, Grattan Institute
Registration for SIEW 2016 is now open. Early bird discounts of up to S$300 will end 30 September 2016. SIEW 2016 will be held from 24 to 28 October 2016 at the Sands Expo and Convention Centre, Marina Bay Sands Singapore.

About Singapore International Energy Week (SIEW)

In its 9th edition, Singapore International Energy Week is the premier platform in Asia for energy insights, partnerships and dialogue, which brings together the world’s leading conferences, exhibitions, and roundtables in one week, one location. SIEW enriches the global energy conversation by convening political, business, academic and energy industry thought-leaders to define and advance the world’s leading energy challenges, solutions and actions across the energy spectrum of oil & gas, clean and renewable energy, and energy infrastructure financing. Please visit http://www.siew.sg for further information.

For media queries, please contact:

Chiu Mei Ji
Energy Market Authority
Tel: +65 6376 7876
Email: chiu_mei_ji@ema.gov.sg

Deborah Yap
Edelman for Singapore International Energy Week
Tel: +65 6494 1562
Email: deborah.yap@edelman.com

Source: Energy Market Authority
Related Links:
http://www.siew.sg

Puma Energy Opens 99th Terminal

JOHANNESBURG /PRNewswire/ —

TERMINAL BUILT IN MATADI, DEMOCRATIC REPUBLIC OF CONGO

Puma Energy, the global mid and downstream energy company, is pleased to announce the opening of its 99th bulk fuel storage terminal at Matadi in the Democratic Republic of Congo (DRC).

Puma Energy has a wealth of experience in the construction, maintenance and operation of terminals and offshore mooring systems to the highest international standards. This advanced terminal is equipped to handle a variety of product types including Gasoline, Jet Fuel and Gasoil. It is an important hub for the shipment and distribution of petroleum products, providing security of product supply to DRC and its neighbouring countries.

The terminal was a detailed and large scale construction project including the creation of four, 6,500m3 Clean Fuels Storage Tanks complete with truck loading and unloading racks. In addition, the site includes a new administration building, a state-of-the-art firefighting system, a floating jetty and interconnecting jetty pipelines, further interconnecting piping with another site and a 2km concrete access road. The terminal and jetty will provide strategic vessel reception capability for DRC and the subregion.

Jonathan Molapo, Puma Energy’s COO for Africa said, “The Matadi terminal will secure the supply of high quality reliable fuels for DRC and the region for the next generation. It has brought employment to the area and we are proud to be helping develop DRC’s infrastructure and supply requirements.”

For further information visit: http://www.pumaenergy.com

Source: Puma Energy
Related Links:
http://www.pumaenergy.com

Laboratorios SALVAT S.A. and Arbor Pharmaceuticals, LLC Announce the Launch of OTOVEL® (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %) otic solution

BARCELONA, Spain and ATLANTA /PRNewswire/ —

Laboratorios SALVAT S.A. (Salvat) and Arbor Pharmaceuticals, LLC (Arbor) jointly announce the launch of OTOVEL® (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %) otic solution, the first and only antibiotic and steroid combination ear drop available in single, sterile, preservative-free, unit-dose packaging. OTOVEL is owned by Salvat and Arbor will be the exclusive distributor of the product in the U.S.

“We are very pleased to be partnering with Salvat to represent OTOVEL in the U.S.” said Ed Schutter, President and CEO of Arbor. “OTOVEL is a perfect fit with our other pediatric products that are sold by our team of over 200 sales professionals throughout the country.”

“It is exciting to further expand the international commercial availability of OTOVEL through the partnership with Arbor in the U.S.” said Alberto Bueno, CEO of Salvat. “This new launch of OTOVEL is a major milestone for Salvat as we continue to grow our presence in the U.S. market.”

About OTOVEL®

OTOVEL® (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %) is indicated for the treatment of acute otitis media with tympanostomy tubes (AOMT) in pediatric patients (aged 6 months and older) due to S. aureus, S. pneumoniae, H. influenzae, M. catarrhalis, and P. aeruginosa. Two phase 3 multicenter, randomized, double-blind, active-controlled, parallel group trials were conducted to assess the efficacy and safety of OTOVEL compared to ciprofloxacin otic solution and to fluocinolone acetonide otic solution. In total 662 pediatric patients (aged 6 months to 12 years old) with AOMT were included. In both trials, the OTOVEL treatment arms showed significantly shorter times to cessation of otorrhea in comparison to both the ciprofloxacin and fluocinolone acetonide alone arms. In Study 1 and Study 2 the median time to cessation of otorrhea in the OTOVEL group was 3.75 days and 4.94 days, respectively.

OTOVEL® is packaged in sterile, single-use vials, with each vial containing a delivery volume of 0.25 mL sterile, preservative-free solution. OTOVEL is promoted and distributed by Arbor and is now available nationwide.

About Acute Otitis Media with Tympanostomy Tubes (AOMT)

Acute otitis media (AOM) is an inflammation of the middle ear space, behind the eardrum (tympanic membrane),that usually results from infection. The infection often results in fluid accumulation (effusion) within the middle ear, increasing pressure on the eardrum. This pressure can cause fever, ear pain, and problems with hearing in affected patients. Children that have recurrent AOM may have tympanostomy tubes inserted through a small incision in the eardrum to help facilitate drainage of fluid from the middle ear. Approximately 1 million children undergo placement of tubes in the United States every year. While the insertion of tubes may help reduce the recurrence of AOM, recent studies report that 83% of children with tympanostomy tubes in place for 18 months will experience at least one episode of AOMT. The clinical presentation of AOMT is different than AOM in children with an intact eardrum in that pain and fever are much less common. The most common symptom of AOMT is fluid drainage from the ear (otorrhea).

IMPORTANT SAFETY INFORMATION FOR OTOVEL

INDICATION

OTOVEL is indicated for the treatment of acute otitis media with tympanostomy tubes (AOMT) in pediatric patients (aged 6 months and older) due to S. aureus, Streptococcus S. pneumoniae, H. influenzae, M. catarrhalis and P. aeruginosa.

IMPORTANT SAFETY INFORMATION

Contraindications

OTOVEL is contraindicated in:

Patients with known hypersensitivity to fluocinolone acetonide or other corticosteroids, ciprofloxacin or other quinolones, or to any other components of OTOVEL.
Viral infections of the external ear canal, including varicella and herpes simplex infections and fungal otic infections.
Warnings and Precautions

Hypersensitivity Reactions – OTOVEL should be discontinued at the first appearance of a skin rash or any other sign of hypersensitivity. Serious and occasionally fatal hypersensitivity (anaphylactic) reactions, some following the first dose, have been reported in patients receiving systemic quinolones. Some reactions were accompanied by cardiovascular collapse, loss of consciousness, angioedema (including laryngeal, pharyngeal or facial edema), airway obstruction, dyspnea, urticaria and itching. Serious acute hypersensitivity reactions may require immediate emergency treatment.

Potential for Microbial Overgrowth with Prolonged Use – Prolonged use of OTOVEL may result in overgrowth of non-susceptible bacteria and fungi. If the infection is not improved after one week of treatment, cultures should be obtained to guide further treatment. If such infections occur, discontinue use and institute alternative therapy.

Continued or Recurrent Otorrhea – If otorrhea persists after a full course of therapy, or if two or more episodes of otorrhea occur within 6 months, further evaluation is recommended to exclude an underlying condition such as cholesteatoma, foreign body, or a tumor.

Adverse Reactions

Clinical trials experience: the most common adverse events that occurred in >1 patient were, otorrhea, excessive granulation tissue, ear infection, ear pruritus, tympanic membrane disorder, auricular swelling and balance disorder.

For additional safety information, consult the Otovel full Prescribing Information [provide e-link to PI].

About Salvat

Laboratorios SALVAT is a privately owned pharmaceutical group closely identified with technological innovation and strongly committed to R&D. Founded in 1955, Salvat is headquartered in Barcelona (Spain) and its US subsidiary, Salvat USA, is located in Miami, FL. Salvat is present in over 60 countries and keeps strenghtening its international presence through the licensing of its own developments. The company launched CETRAXAL® (ciprofloxacin 0.2 %) otic solution in the US in 2009 and received FDA approval for OTOVEL® (ciprofloxacin 0.3 % and fluocinolone acetonide 0.025 %) otic solution in April 2016. Additional information regarding Laboratorios SALVAT and its products is available at http://www.salvatbiotech.com

About Arbor

Arbor Pharmaceuticals, headquartered in Atlanta, Georgia, is a specialty pharmaceutical company currently focused on the cardiovascular, hospital and pediatric markets. The company has over 600 employees including 500 sales professionals promoting its products to physicians, hospitals, and pharmacists. Arbor currently markets 20 NDA and ANDA approved products with over 40 more in development. For more information regarding Arbor Pharmaceuticals or any of its products, visit http://www.arborpharma.com or send email inquiries to info@arborpharma.com.

For more information about SALVAT or the Company’s products, please visit http://www.salvatbiotech.com.

For more information about ARBOR or the Company’s products, please visit http://www.arborpharma.com.

CONTACTS:
Laboratorios SALVAT S.A.
Alberto Bueno
Chief Executive Officer
abueno@salvatbiotech.com

Francesc Rosell
International Director
frosell@salvatbiotech.com

Enrique Jimenez, MD
Medical Director
ejimenezv@salvatbiotech.com

Arbor Pharmaceuticals, LLC
Ed Schutter
President & CEO
eschutter@arborpharma.com
+1-678-334-2421

Brian Adams
Head of Business Development
badams@arborpharma.com
+1-404-496-5915

Source: Laboratorios SALVAT and Arbor Pharmaceuticals

Evercore Announces Expansion of M&A Alliance with South Korea’s NH Investment & Securities

NEW YORK and SEOUL, South Korea/PRNewswire/ —

Evercore (NYSE: EVR), a leading independent investment banking advisory firm headquartered in New York, USA and NH Investment & Securities (“NH”), the leading South Korea-based investment bank, announced today they have extended their strategic alliance for cross-border M&A advisory services for an additional two year period and expanded it to operate on an exclusive basis between the U.S. and South Korea. The advisory alliance enables Evercore and NH to continue to capitalize on what we believe to be a positive long term trend driving cross-border M&A activity in Asia.

Founded in 1995, Evercore is the #1 ranked independent firm year-to-date in US M&A and is an M&A market leader in the TMT, Financial Services, Energy and Healthcare sectors. Evercore’s advisory revenue growth since 2010 is the highest among all publicly traded investment banks. Evercore ISI, Evercore’s equities platform, is the #1 ranked independent research analyst platform by Institutional Investor and #3 ranked among all firms.

NH Investment & Securities was formed by the merger of Woori IS and Nonghyup Securities in 2014 and is one of the largest investment banks in Korea by total assets. NH has held a prominent position in the Korean investment banking market for more than 53 years and is the leading domestic underwriter for equity securities, including initial public offerings, and the top domestic firm in the Korean M&A league tables for over the past 6 years.

Ralph Schlosstein, Evercore’s President and Chief Executive Officer said, “We are pleased to extend and expand our Alliance with NH, which we established in 2011. Our longstanding relationship with NH is an important part of our global strategy and enables Evercore and NH to serve domestic Korean clients and international clients with strategic interests in Korea. We are pleased to be working together with NH, a premier partner with deep client relationships in the Korean market.”

Young-Chae Jeong, Executive Vice President and Head of Investment Banking Division commented, “We look forward to continuing our partnership with Evercore so that we can together provide the highest quality M&A advice and create the opportunity to better serve our clients around the world.”

About Evercore

Established in 1995, Evercore is a leading global independent investment banking advisory firm. Evercore advises a diverse set of investment banking clients on a wide range of transactions and issues and provides institutional investors with high quality equity research, sales and trading execution that is free of the conflicts created by proprietary activities. The Firm also offers investment management services to high net worth and institutional investors. With 28 offices in North America, Europe, South America and Asia, Evercore has the scale and strength to serve clients globally through a focused and tailored approach designed to meet their unique needs. More information about Evercore can be found on the Company’s website at http://www.evercore.com.

About NH Investment & Securities

NH Investment & Securities Co., Ltd., formerly known as Woori Investment & Securities Co. Ltd. provides a range of financial services in South Korea and internationally. It offers various investment banking services, including equity and debt underwriting; advisory services for mergers and acquisitions, project financing, and private equity funds; and financial solutions for corporate clients. The company also engages in trading stocks, bonds, derivatives, futures, and options; client book trading; and maintaining portfolios, as well as international brokerage operations. In addition, it provides wealth management services consisting of brokerage and asset management consulting services through the development and sale of various financial products, such as beneficiary certificates, bond investments, mutual funds, equity-linked securities, CP, RP, and WRAP accounts. Further, the company offers merchant banking services, including short-term lending, such as commercial papers; deposit business comprising notes issued and cash management accounts; and structured deals for non-performing loans, project financing, and asset-backed loans. The company is headquartered in Seoul, South Korea and operates through 88 branches, 6 overseas subsidiaries, and 2 overseas offices in London, New York, Hong Kong, Singapore, Beijing, Shanghai, Indonesia, and Vietnam. More information on NH Investment & Securities Co., Ltd. can be found on the Company’s website at http://www.nhqv.com.

Evercore Investor Contact:
Robert B. Walsh
Chief Financial Officer, Evercore
+1.212.857.3100

NH Investor Contact:
Esther Lee
Investor Relations
+82.2.768.7351

Media Contact:
Dana Gorman
The Abernathy MacGregor Group, for Evercore
+1.212.371.5999

Source: Evercore
Related stocks: NYSE:EVR
Related Links:
http://www.evercore.com

SIR IVAN’s “Imagine” Ranks Top 10 In The World 45 Years After John Lennon’s Original

NEW YORK /PRNewswire/ — Music history was made this month as pop star and philanthropist SIR IVAN went Top 10 with an all new uptempo version of John Lennon’s “Imagine”, on three significant industry charts, 45 years after the original release in 1971.

In the U.K. where John Lennon was born, “Imagine” by SIR IVAN ranks # 9 on Music Week’s Commercial Pop Chart. SIR IVAN entered the radio chart in August along with Selena Gomez, Bob Sinclar, Usher and Calvin Harris.

In the U.S., John Lennon’s adopted home, “Imagine” by SIR IVAN coincidentally also ranks # 9 on the DJ Times National Dance/Crossover Top 40 Chart. The DJ Times is the oldest and most respected magazine for professional DJs in America. SIR IVAN entered the club chart along with Justin Timberlake, Justin Bieber, Sia, Sean Paul and Rihanna.

New Zealand based SERATO’S promotion division, Serato White Label, ranks “Imagine” by SIR lVAN # 1 for the greatest amount of DJ downloads during the month of July. SERATO is the leading DJ equipment and software manufacturer in the world. Although SIR IVAN sits on the top of the chart, he was also joined by Gwen Stefani, M.I.A. and Imany.

SIR IVAN’s new electronic dance music (EDM) version of “Imagine” (http://bit.ly/2bzzO9D) spent weeks on the Billboard Dance Club Chart. The song was co-produced by Grammy Award winner Omar Akram and legendary music arranger Peter Rafelson. It has been praised globally and fans of both the original and the new are dancing and working out to the most iconic peace song ever written. “Imagine” is the first single released off SIR IVAN’s new 10 song album called “Peaceman Shines” (http://bit.ly/2c9Yryf). Each of the 10 songs, created by 10 different producers, are well known anti-war or peace songs from the 60s and early 70s, except for two original songs, co-written by SIR IVAN, that share the same theme.

This is not the first time SIR IVAN has released an uptempo version of “Imagine.” He did so on September 4th, 2001, exactly one week before September 11th, when he launched his music career and became the first recording artist in history to turn any slow ballad of the Beatles or John Lennon into an uptempo dance record. Personally signed to the Tommy Boy label by its owner, Tom Silverman, SIR IVAN’s revolutionary fast paced version of “Imagine” became an instant Top 40 hit on the Billboard Dance Club Chart. This proved that even thirty years after the original was released by John Lennon in 1971, the lyrics of “Imagine” were just as relevant to a whole new generation. Now, 15 years after SIR IVAN first turned the ballad into a dance record, and because terrorist attacks are occurring all over the world, he is once again giving the planet an opportunity to heal itself through the therapeutic power of music. He urges us to come together as one, while raising money for a worthy cause.

In 2005, SIR IVAN, son of Auschwitz survivor Siggi B. Wilzig, created The Peaceman Foundation, a charity that donates funds to other non-profit organizations that help people suffering from Post-Traumatic Stress Disorder (PTSD). PTSD is a debilitating mental condition that often results from exposure to severe acts of violence, such as physical attacks against members of the LGBT community, atrocities of war and terrorism. SIR IVAN has seen firsthand what survivors go through. His own father suffered from classic PTSD symptoms; fierce headaches, flashbacks, nightmares and depression, as a result of brutal beatings in the concentration camps and the murder of 59 members of his family during the Holocaust. All of SIR IVAN’s recording artist royalties from the single “Imagine” and the album “Peaceman Shines” will be donated to The Peaceman Foundation to battle PTSD and provide treatment for the psychological wounds caused by hatred and violence. Both are available on iTunes, Amazon MP3, and many other top digital music stores. Physical CDs can be purchased at CD baby.

SIR IVAN’s “Imagine” on iTunes: https://itun.es/us/U99Tcb
SIR IVAN’s album “Peaceman Shines” on iTunes: https://itun.es/us/D-pXcb

For information on SIR IVAN and The Peaceman Foundation – please follow the below links:
http://www.SirIvan.com and http://www.SirIvan.com/The-Peaceman-Foundation

Source: Peaceman Music
Related Links:
http://www.SirIvan.com

Thai Students Win 2016 Stockholm Junior Water Prize for Natural Innovative Water Retention Device

STOCKHOLM /PRNewswire/ —

Three students from Thailand, Sureeporn Triphetprapa, Thidarat Phianchat and Kanjana Komkla, received the 2016 Stockholm Junior Water Prize on Tuesday for their innovative water retention device that mimics the water retention of the Bromeliad plant. H.R.H. Prince Carl Philip of Sweden presented the prize at an award ceremony during World Water Week in Stockholm.

By examining the efficacy of natural water collection by plants – especially in terms of the shape of plants that collect and capture water – Sureeporn Triphetprapa, Thidarat Phianchat and Kanjana Komkla built a device that mimics the water retention of the Bromeliad plant. The device has also been installed on rubber trees on rubber plantations. For this, they have been awarded the 2016 Stockholm Junior Water Prize, showcasing that nature is the best teacher.

The Jury was impressed by the winners’ exceptional creativity, unrelenting diligence, enthusiasm and true passion for water.

“The winning project addresses future water security and rural livelihoods using an elegant leap-frog technology which looks simple, but its beauty masks its complexity!” the Jury said in its citation.

“It has already proven to be scalable and is now being tested in the field, by hundreds of farmers, who are now benefiting from the inspiration from beautiful plants which have an exceptional capacity to collect and store water.”

Asked how she would want to take the winning project further, Sureeporn Triphetprapa said: “I will use our idea to relieve poverty in our community.”

“This shows that to make real progress towards achieving the Sustainable Development Goals, we need to start at the local level. This is a very good example of that; a simple, smart and scalable solution, making a big difference,” said Torgny Holmgren, Executive Director of SIWI.

The Stockholm Junior Water Prize competition brings together the world’s brightest young scientists to encourage their continued interest in water and the environment. This year, thousands of participants in countries all over the globe joined national competitions for the chance to represent their nation at the international final held during the World Water Week in Stockholm. Teams from 29 countries competed in the 2016 finals.

Information about Stockholm International Water Institute, Stockholm Junior Water Prize and World Water Week: http://www.siwi.org and http://www.worldwaterweek.org

Press contact: Susanne Hedberg, Communications Officer, Tel +46-8-1213-6036

Source: Stockholm International Water Institute
Related Links:
http://www.siwi.org/

Poorly Conceived FinTech Lending Models Could Have Unintended Consequences

SINGAPORE /PRNewswire/ —

Poorly designed credit risk models can harm consumers, lenders, investors and the overall financial system
Fintech companies that circumvent regulations may be putting their customers and themselves at risk
The best credit risk models have five key attributes — predictive power, broad coverage, fairness, transparency and the ability for the consumer to dispute the process when mistakes are made
Recent trouble at marketplace lenders such as Lending Club has led many in the industry to say the fintech bubble is bursting. Whether or not this proves to be true, it is important to explore the unintended dangers posed by some of the new ways fintech companies are attempting to assess risk, as Dr. Andrew Jennings, senior vice president for Scores, posted on the Fair Isaac Corporation (FICO) Blog.

A large body of regulation has built up in the U.S. to provide consumer protections related to the use of personal data, underwriting criteria and marketing practices. “Fintech business models that circumvent or violate these regulations could pose significant unintended dangers, including negative impacts for consumers, lenders, investors and the overall financial system,” Jennings said.

“In the lending industry, bad credit-risk models often lead to bad lending decisions. We need look no further than the recession of 2008-2009 for a reminder. Bad decisions can be devastating for consumers who get overextended. The decisions can also result in massive losses for investors, unsustainable business conditions for lenders, and a weakening of the financial system.

“For example, should regulators (or the lenders themselves) today take a closer look at risk models in China where delinquency rates are near 25 percent in the P2P lending market? By comparison, delinquencies on credit cards in China are in the 3-5 percent range. At the very least, this indicates a possible need for new risk tools to guide underwriting policies in P2P lending.”

The best credit-risk models, Jennings said, have five key attributes — predictive power, broad coverage, fairness, transparency, and the ability for the consumer to dispute the process when mistakes may have been made.

“It isn’t always possible to build all of these attributes into every model, but it is important that data scientists try to include all of them in their models,” Jennings wrote. “It is particularly difficult to reach this gold standard when models have opaque variables, rely on data that could be easily gamed, or are so complex that problems can’t be diagnosed when the models fail. These are the dangers with many of the scoring models being touted by fintech companies.”

For example, transparency is important in credit markets because it helps ensure greater fairness and accessibility. If a consumer receives a low FICO® Score, a reason code like “balances too high” is clear and actionable. “But if, for example, a score uses data on a person’s educational background, what can be done when the score is low?” Jennings wrote. “Tell that person that should have attended a better college or read a different subject or attained a higher grade?”

“Such data is often predictive but would be problematic on many of the key requirements of a best-in-class risk model. Designers of alternative credit-risk scores may not intend to illegally harm anyone, but the unintended dangers of their models may result in unreliable lending decisions and/or widespread bias against certain groups of people.”

Care must be taken to ensure the process works for all participants by embracing innovations that spur a healthy marketplace while avoiding the dangers of poorly designed risk models.

For discussion of this and related topics from Dr. Jennings and other FICO experts, subscribe to the FICO Blog.

About FICO

FICO (NYSE: FICO) powers decisions that help people and businesses around the world prosper. Founded in 1956 and based in Silicon Valley, the company is a pioneer in the use of predictive analytics and data science to improve operational decisions. FICO holds more than 165 US and foreign patents on technologies that increase profitability, customer satisfaction and growth for businesses in financial services, telecommunications, health care, retail and many other industries. Using FICO solutions, businesses in more than 100 countries do everything from protecting 2.6 billion payment cards from fraud, to helping people get credit, to ensuring that millions of airplanes and rental cars are in the right place at the right time. Learn more at http://www.fico.com.

Join the conversation at https://twitter.com/fico & http://www.fico.com/en/blogs/

For FICO news and media resources, visit http://www.fico.com/news.

FICO is a registered trademark of Fair Isaac Corporation in the United States and in other countries.

Source: Fair Isaac Corporation (FICO)
Related stocks: NYSE:FICO
Related Links:
http://www.fico.com